Variability of bacterial vaginosis over 6- to 12-month intervals

Sexually Transmitted Diseases

Volumn 33, Issue 6, 2006, Pages 381-385

  Ness, Roberta B ^a,b,g   Kip, Kevin E ^a   Soper, David E ^d   Stamm, Carol A ^e   Rice, Peter ^c   Richter, Holly E ^f  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e DENVER HEALTH MEDICAL CENTER   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHLAMYDIASIS; CONFERENCE PAPER; EDUCATION; EXPOSURE; FEMALE; FOLLOW UP; GONORRHEA; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; MONOGAMY; NEGRO; RISK FACTOR; SEXUAL BEHAVIOR; STATISTICAL MODEL; UTERINE CERVICITIS; VAGINA FLORA; VAGINA SMEAR; VAGINITIS;

ADOLESCENT; ADULT; EDUCATION; ETHNIC GROUPS; FEMALE; HUMANS; LONGITUDINAL STUDIES; RISK FACTORS; UNITED STATES; VAGINAL SMEARS; VAGINOSIS, BACTERIAL;

EID: 33744812417     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000204748.89222.33     Document Type: Conference Paper

References (29)

1. Schwebke JR. Gynecologic consequences of bacterial vaginosis. Obstet Gynecol North Am 2003; 30:685-694.
2. Morris M, Nicoll A, Simms I, et al. Bacterial vaginosis: a public health review. Br J Obstet Gynaecol 2001; 108:439-450.
3. Martin HL, Richardson BA, Myange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
4. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996; 175:435-441.
5. Peipert JR, Montagno AB, Cooper AS, et al. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 1997; 177:1184-1187.
6. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003; 36:663-668.
7. Korn AP, Bolan G, Padian N, et al. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1995; 85:387-390.
8. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004; 80:8-11.
9. Klebanoff MA, Hauth JC, MacPherson CA, et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 2004; 190:363-370.
10. Larsson PB. Treatment of bacterial vaginosis. Int J STD AIDS 1992; 3:239-247.
11. Boris J, Pahlson C, Larsson PG. Six-year follow-up after successful treatment of bacterial vaginosis. Int J STD AIDS 1997; 8(suppl 1):41.
12. Ness RB, Hillier SL, Kip KE, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004; 104:761-769.
13. Ness RB, Hillier SL, Richter HE, et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 2002; 100:765-772.
14. Stergachis A, Scholes D, Heidrich FE, et al. Selective screening for chlamydia infection in a primary care population of women. Am J Epidemiol 1993; 138:143-153.
15. Schwebke JR, Hillier SL, Sobel JD, et al. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996; 88:573-576.
16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standard method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
17. Allison PD. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute, 1995.
18. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: Wiley, 2000.
19. Royce RA, Jackson TP, Thorp JM Jr, et al. Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis 1999; 26:96-102.
20. Holzman C, Leventhal JM, Qiu H, et al. Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health 2001; 91:1664-1670.
21. Rajamanoharan S, Low N, Jones SB, et al. Bacterial vaginosis, ethnicity, and the use of genital cleaning agents: a case control study. Sex Transm Dis 1999; 26:404-409.
22. Ness RB, Hillier S, Richter HE, et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc 2003; 95:201-212.
23. Hoffman SC, Stanley EM, Cox ED, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transpl 2002; 2:560-567.
24. Martin A-M, Athanasiadis G, Greshock J. Population frequencies of single nucleotide polymorphisms (SNPS) in immuno-modulatory genes. Hum Hered 2003; 55:171-178.
25. Spandorfer SD, Neuer A, Giraldo PC, et al. Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J Reprod Med 2001; 46:806-810.
26. Yudin MH, Landers DV, Meyn L, et al. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003; 102:527-534.
27. Imseis HM, Greig PC, Livengood CH 3rd, et al. Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. J Soc Gynecol Investig 1997; 4:90-94.
28. Ness RB, Haggerty CL, Harger G, et al. Differential distribution of allelic variants in cytokine genes among African Americans and white Americans. Am J Epidemiol 2004; 160:1033-1038.
29. Ness RB, Hillier SL, Kip KE, et al. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am J Epidemiol 2005; 161:186-195.